腎臓移植を受けた長期患者および血液透析を受けている患者の精神病的罹患率. 比較研究という比較研究です
JAMA
|July 1, 1983
まとめ
精神疾患の罹患率は,長期間腎臓移植を受けた患者と血液透析患者で同等に高い. 治療の選択は,慢性腎不全における精神疾患の流行に影響を与えないようです.
科学分野:
- ネフロロジーはネフロロジーを用います.
- 精神科医は精神病を患っている.
- 移植医療 移植医療について
背景:
- 慢性腎不全 (CRF) は重大な医療介入を必要とし,患者の精神的健康に影響を及ぼします.
- 長期的な腎置換療法には,腎臓移植と血液透析が含まれます.
- 以前の仮定は,透析よりも移植の心理的な利点を示唆しました.
研究 の 目的:
- 腎臓移植を受けた長期患者と血液透析を受けている患者の精神病的罹患率を比較する.
- CRF患者における治療方法と心理的幸福の関係を調査する.
- これらの患者グループにおける精神障害の有病率を評価する.
主な方法:
- 慢性腎不全患者の2つのグループを比較した横断的研究.
- 人口統計データを収集し,精神疾患の罹患率を評価するためにアンケートを使用しました.
- 一般健康アンケートを使用し,精神科治療歴をレビューしました.
主要な成果:
- 精神疾患の有意な差は,移植受容者 (46%) と血液透析患者 (48%) の間で認められませんでした.
- ヘモダイアリスの患者は,移植を受けた患者よりも高齢で,医学的に病気でした.
- 精神障害の高い割合は,両方のグループで観察されました.
結論:
- 慢性腎不全の患者では,治療の種類に関係なく,精神疾患の罹患率が高い.
- ヘモダイアリシスに対する腎臓移植の心理的利点は,この研究の発見によって支持されていません.
- 慢性腎不全のすべての患者にとって,精神保健のサポートは極めて重要です.
関連する概念動画
01:24Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...